Ohiohealth Research Institute

Ohiohealth Research Institute, a Columbus, Ohio-based nonprofit hospital and research entity, operates as a prime recipient on federal health services and research grants (28% of recent awards) and as a sub-recipient on clinical research and public health initiatives (72% of recent awards). The organization holds no federal contracts and does not sit on contract vehicles; its federal footprint is grant-based, focused on addiction medicine training, trauma-informed behavioral health services, sexual violence prevention and response, and clinical research implementation across Ohio's rural and underserved communities.

Ohiohealth's federal grant portfolio centers on substance abuse, mental health, and violence-related services. As prime recipient, the organization received $749,998 from the Substance Abuse and Mental Health Services Administration under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) in September 2026 for the Workforce Expansion Amplifying Victim Empowerment (WEAVE) initiative, which expands trauma-informed behavioral health services and victim advocacy across OhioHealth hospitals and outpatient sites in central Ohio through September 2031. Earlier prime grants include a $400,000 Department of Justice award (CFDA 16.753, Byrne Discretionary Grants) in July 2023 for OhioHealth's Sexual Assault Response Network of Central Ohio to conduct educational campaigns targeting sexual violence survivors and community members aged 18–24 in Franklin County and statewide. The organization also holds an active HRSA-funded Addiction Medicine Fellowship program (award date July 2025, completion June 2030) that trains physicians in evidence-based substance use disorder treatment across Ohio's rural and urban settings, and received HRSA funding for the Rural Communities Opioid Response Program serving Marion County and Franklin County through 2028 and 2027 respectively.

Customer concentration reflects alignment with health and justice priorities. The Department of Justice Office of Justice Programs Victims of Crime accounts for eleven awards; the Department of Health and Human Services Centers for Disease Control and Prevention accounts for ten awards; SAMHSA accounts for five awards; and the National Institute of Neurological Disorders and Stroke accounts for four awards. These four agencies represent 72% of total award count. As a sub-recipient, Ohiohealth partners with Ohio state agencies (Department of Mental Health, Department of Health, Attorney General's Office) on State Opioid Response grants and sexual violence prevention programs, and engages with research-prime institutions including Northwestern University on clinical trials (SPARX3, REACT-AF) and Nationwide Children's Hospital on maternal health equity initiatives. Recent sub-award activity shows recurring roles in state opioid response implementation, sexual violence prevention coordination, and Phase 3 clinical trial participation.

Award activity accelerated from 2022 through 2024, growing from two awards in 2022 to sixteen in 2024, with nine awards recorded in 2025 and one in 2026. Two awards face ultimate completion within the next twenty-four months. The organization's capability footprint spans addiction medicine fellowship training, medication-assisted treatment delivery, trauma-informed behavioral health services, sexual assault crisis response and prevention education, and clinical research site participation, with place of performance concentrated in central Ohio (Columbus, Franklin County, and Marion County) and statewide programming.